relapsed - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC3267864/ Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing - PMC Most patients with acute myeloid leukemia (AML) die from progressive disease after relapse, which is associated with clonal evolution at the cytogenetic... acute myeloid leukemia https://data.mendeley.com/datasets/nh69skddb7/1 Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or... Supplemental Figure for Manuscript https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-00035&r=1 Enasidenib with or without Rituximab for the Treatment of Relapsed and Refractory IDH2-Mutant... Enasidenib with or without Rituximab for the Treatment of Relapsed and Refractory IDH2-Mutant Angioimmunoblastic T-cell Lymphoma https://pubmed.ncbi.nlm.nih.gov/23205612/ A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or... A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma https://pubmed.ncbi.nlm.nih.gov/35118649/ Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective... As treatments for second relapsed and refractory first relapsed paediatric AML transition from purely palliative to more commonly curative in nature,... clinical outcomes https://adisinsight.springer.com/trials/700267120?error=cookies_not_supported&code=c994e154-8b83-4825-a20b-9d8f23890d81 CLARITY: Assessment of VenetoCLAx (ABT-199) in combination with IbRutInib in relapsed/refracTory... This is a feasibility study to investigate the safety and efficacy of ibrutinib combined with venatoclax in patients with relapsed/refractory chronic https://pubmed.ncbi.nlm.nih.gov/36257914/ Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton... Mantle cell lymphoma (MCL) after relapse is associated with poor prognosis. No standard of care exists and available evidence for treatments is limited,... real world experience https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-brentuximab-vedotin-lenalidomide-and-rituximab-relapsed-or-refractory-large-b-cell FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large... On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with... https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-fda-approval-moxetumomab-pasudotox-tdfk-relapsed-or-refractory-hairy-cell-leukemia FDA D.I.S.C.O.: FDA approval of moxetumomab pasudotox-tdfk for relapsed or refractory hairy cell... FDA medical oncologists discuss the Sept. 13, 2018, approval of moxetumomab pasudotox-tdfk for the treatment of patients with relapsed or refractory hairy cell... https://acrossafricanews.blogspot.com/2025/11/us-fda-grants-priority-review-to.html Across Africa News: U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or... If approved, sonrotoclax will become the first BCL2 inhibitor for R/R MCL in the U.S., addressing a high unmet need in an aggressive cancer... https://file.scirp.org/Html/1-2030055_33606.htm Long Lasting Efficiency of Monthly Vinblastine in a Case of Relapsed Anaplastic Large Cell Lymphoma https://experts.umn.edu/en/publications/tisagenlecleucel-in-adult-relapsed-or-refractory-diffuse-large-b-/ Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma - Experts@Minnesota https://open.library.emory.edu/concern/publications/b89d3356-8715-425a-8f7d-f4e28f054a8a Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory... Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma https://pubmed.ncbi.nlm.nih.gov/33502920/ Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma Clinical behavior of relapsed medulloblastoma must be contextualized in terms of up-front therapies and molecular classifications. Group 4 tumors exhibit... clinical outcomes patient matched molecular composition https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-00036&r=1 SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid... SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation https://pubmed.ncbi.nlm.nih.gov/34895487/ Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a... Kite, a Gilead Company. non hodgkin lymphoma https://pubmed.ncbi.nlm.nih.gov/34462189/ Efficacy and safety of GLS-010 (zimberelimab) in patients with relapsed or refractory classical... GLS-010 (zimberelimab) appears to be effective and safe for the treatment of Chinese patients with r/r-cHL. Long-term follow-up is required to confirm these... efficacy and safety https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.969660/full Frontiers | Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large... Chimeric antigen receptor T cell (CAR-T) therapy has emerged as highly effective in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), but only... https://adisinsight.springer.com/trials/700197278?error=cookies_not_supported&code=a5c9682a-61f8-457b-a581-95325ce363f5 A Pilot Study of G-CSF to Disrupt the Bone Marrow Microenvironment in Relapsed or Refractory Acute... This study will investigate the tolerability of filgrastim in increasing the efficacy of chemotherapy (ifosfamide + etoposide + dexamethasone + mesna) for https://adisinsight.springer.com/trials/700386367?error=cookies_not_supported&code=3e9c73b0-d0a8-4748-b28f-4489244cb303 zAvatar test-guided therapeutic decision vs standard of care, in relapsed ovarian cancer and in... Evaluate the zAvatar-test as a predictive model of treatment efficacy to aid therapeutical decisions, in patients with relapsed ovarian cancer and in patients https://adisinsight.springer.com/trials/700320732?error=cookies_not_supported&code=76c682b5-bb26-4b4f-ae9d-b7383b78d2b7 A Phase 2 Study of Zafirlukast for the Treatment of Tumor-marker Only Relapsed Ovarian Cancer -... This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity in participants with tumor marker-only relapsed ovarian cancer. - https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03792633&r=1 Modified Immune Cells (huCART19) in Treating Pediatric Patients with Relapsed or Refractory Very... Modified Immune Cells (huCART19) in Treating Pediatric Patients with Relapsed or Refractory Very High-Risk B Acute Lymphoblastic Leukemia https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/an-openlabel-phase-iii-study-of-jcar017-in An Open-Label, Phase I/II Study of JCAR017 in Subjects with Relapsed or Refractory Chronic... An Open-Label, Phase I/II Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004) https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1404351/full Frontiers | Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell... The short-term complications from CART are well characterized, but the long-term complications still need to be further investigated. Therefore, herein, we w... car t cell therapy https://pubmed.ncbi.nlm.nih.gov/35844690/ A registry study of relapsed or refractory multiple myeloma pre-exposed to three or more prior... Some patients with multiple myeloma are receiving treatment in clinical practice in England after prior exposure to a proteasome inhibitor, an immunomodulatory... https://www.prnewswire.com/news-releases/data-from-phase-2-ace-study-of-ambits-quizartinib-in-patients-with-relapsed-or-refractory-acute-myeloid-leukemia-aml-presented-at-18th-congress-of-the-european-hematology-association-213111161.html Data from Phase 2 ACE Study of Ambit's Quizartinib in Patients with Relapsed or Refractory Acute... /PRNewswire/ -- Ambit Biosciences Corporation (Nasdaq: AMBI) announced today data from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were... https://research.monash.edu/en/projects/international-study-for-treatment-of-relapsed-high-risk-childhood-2/ International study for treatment of relapsed high risk childhood ALL (HR-ALL) - Monash University https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=39513 LCD - Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and... Use this page to view details for the Local Coverage Determination for Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin... for primary https://boris-portal.unibe.ch/entities/publication/7f0602d5-8d68-4d3b-9cf4-5d55ae9422f5 Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple... Long-term disease control in multiple myeloma (MM) is typically an unmet medical need, and most patients experience multiple relapses. Fluorescence in situ... https://www.cirm.ca.gov/cirm-trial/fecal-microbiome-transplant-to-remodel-intestinal-microbiota-for-patients-with-relapsed-or-refractory-lymphoma-with-exposure-to-high-risk-antibiotics-who-are-receiving-chimeric-antigen-receptor-t-ce-2/ Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or... https://cris.tau.ac.il/en/publications/real-world-experience-with-belantamab-mafodotin-therapy-for-relap/fingerprints/ Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A... real world experience https://profiles.wustl.edu/en/publications/isatuximab-as-monotherapy-and-combined-with-dexamethasone-in-pati/ Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory... in patients combined https://scholars.duke.edu/publication/1431799 Scholars@Duke publication: Rindopepimut with Bevacizumab for Patients with Relapsed... for patients scholars duke publication bevacizumab https://adisinsight.springer.com/trials/700294236?error=cookies_not_supported&code=b07e5bfa-bafd-4afa-8c0f-3f382aac1a9d A Phase I Trial of Palbociclib in Combination With Dexamethasone in Relapsed or Refractory Adult... This single arm, phase I, dose escalation trial is to evaluate the side effects and best dose of palbociclib when given together with dexamethasone in treating https://adisinsight.springer.com/trials/700392431?error=cookies_not_supported&code=d84a4aca-756f-4eef-bfcb-a049d34dd077 Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma... The Double-T trial is a prospective, randomized, single-arm, open-label, multicenter phase II trial investigating a double T-cell therapy strategy, which https://ec2-3-220-198-172.compute-1.amazonaws.com/blood-2024027342-multiple-myeloma/ Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG... May 16, 2025 - Is the need to transplant declining? Salvage autologous transplant vs lenalidomide/dexamethasone offers no significant survival benefit in RRMM. Patients who... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1491341/full Frontiers | Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid... BackgroundHuman C-type lectin-like molecule 1 (CLL-1) represents a promising therapeutic target for Chimeric antigen receptor T (CAR-T) cells therapy in the ... https://cordis.europa.eu/project/id/278514/de International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic... Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood cancer. Given the... https://experts.arizona.edu/en/publications/a-phase-2-study-of-vorinostat-for-treatment-of-relapsed-or-refrac/ A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest... https://gamblingtherapy.org/uk/forum/topic/i-relapsed-again/ I Relapsed Again - Gambling Therapy If you read my last post, you know that I am unemployed with no money coming in. Unfortunately, I relapsed again. I sold one of the last things I had that had... relapsed gambling therapy https://www.cirm.ca.gov/cirm-trial/modified-immune-cells-cd19-car-t-cells-and-acalabrutinib-for-the-treatment-of-relapsed-or-refractory-mantle-cell-lymphoma-2/ Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or... https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1347547/full Frontiers | Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's... Introduction: Anthracyclines are effective in treating acute myeloid leukemia (AML) but limited by cardiotoxicity. CPX-351, a liposomal daunorubicin and cyta... https://www.cochrane.org/de/evidence/CD011322_use-hormonal-treatment-relapsed-epithelial-ovarian-cancer The use of hormonal treatment in relapsed epithelial ovarian cancer | Cochrane the use hormonal treatment ovarian cancer https://pubmed.ncbi.nlm.nih.gov/38640348/ Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory... Ivosidenib is a first-in-class mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor with efficacy and tolerability in patients with advanced mIDH1 hematologic... https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-epkinly-epcoritamab-bysp-relapsed-or-refractory-diffuse-large-b FDA D.I.S.C.O. Burst Edition: FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory... Listen to a soundcast of the May 19, 2023, FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma and high-grade... https://www.wikidata.org/wiki/Q73968476 Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia - Wikidata scientific article published on 01 June 2000 acute lymphoblastic leukaemia methotrexate resistance relapsed childhood https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=39434 LCD - Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's... Use this page to view details for the Local Coverage Determination for Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed... for primary https://www.ncbi.nlm.nih.gov/books/NBK592405/ Relapsed and Refractory Multiple Myeloma - StatPearls - NCBI Bookshelf Multiple myeloma (MM) is a malignant disorder of B cells that involves the proliferation of abnormal monoclonal plasma cells in the bone marrow and/or... multiple myeloma relapsed refractory ncbi bookshelf https://ashleyisawife.blogspot.com/2012/02/i-confess-i-have-relapsed.html?showComment=1329529704805 Life After the Aisle: I Confess I Have Relapsed I confess... I have relapsed. It is so so sad - I have been doing so well. Ugh! I'm thinking if I blog about it - I will feel like I ... after the aisle life confess relapsed https://www.nice.org.uk/guidance/indevelopment/gid-ta11052 Project information | Linvoseltamab for treating relapsed or refractory multiple myeloma after 3 or... Linvoseltamab for treating relapsed or refractory multiple myeloma after 3 or more treatments [ID6609] project information https://pubmed.ncbi.nlm.nih.gov/38889737/ Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1):... https://www.researchandmarkets.com/reports/5638072/relapsedrefractory-epstein-barr-virus-infection Relapsed/Refractory Epstein Barr Virus Infection Associated Disorders - Pipeline Insight, 2025 Relapsed/Refractory Epstein Barr Virus Infection Associated Disorders - Pipeline Insight, 2025 epstein barr virus associated disorders relapsed refractory https://publikationen.uni-tuebingen.de/xmlui/handle/10900/57289 Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory... https://pubmed.ncbi.nlm.nih.gov/41689916/ Outcomes of tisagenlecleucel versus allogeneic hematopoietic stem cell transplantation in relapsed... Tisa-cel provides disease control comparable to allo-HSCT while markedly reducing NRM, resulting in a clear survival advantage when relapse occurs within 18... stem cell transplantation outcomes tisagenlecleucel versus allogeneic https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-02972&r=1 Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or... Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies https://umu.diva-portal.org/smash/record.jsf?pid=diva2%3A1992887 Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory... https://pubmed.ncbi.nlm.nih.gov/26639348/ Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia Selective targeting of BCL2 with venetoclax had a manageable safety profile and induced substantial responses in patients with relapsed CLL or SLL, including... targeting venetoclax relapsed chronic leukemia https://pubmed.ncbi.nlm.nih.gov/26704623/?dopt=Abstract Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy Nearly half the patients had visible disease in multiparametric MRI despite low PSA. Positive lymph nodes incidence should be considered when planning salvage... prostate cancer pelvic mri findings relapsed https://fis.tu-dresden.de/portal/en/publications/phase-ii-clinical-trial-of-pazopanib-in-patients-with-acute-myeloid-leukemia-aml-relapsed-or-refractory-or-at-initial-diagnosis-without-an-intensive-treatment-option-pazoaml(c358453f-17c7-4c6f-bb90-f8c5217f8736).html Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or... https://refubium.fu-berlin.de/handle/fub188/15875 Refubium - Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood... minimal residual disease https://pubmed.ncbi.nlm.nih.gov/35875118/ Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm,... Penpulimab was effective and safe in patients with R/R cHL. https://pubmed.ncbi.nlm.nih.gov/39821392/ A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or... ClinicalTrials.gov ID NCT03772925, first posted 12/12/2018; CTEP Identifier 10246. https://ashleyisawife.blogspot.com/2012/02/i-confess-i-have-relapsed.html?showComment=1329640800043 Life After the Aisle: I Confess I Have Relapsed I confess... I have relapsed. It is so so sad - I have been doing so well. Ugh! I'm thinking if I blog about it - I will feel like I ... after the aisle life confess relapsed https://pure.psu.edu/en/publications/phase-i-study-of-panobinostat-plus-everolimus-in-patients-with-re/ Phase i study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma -... phase i study https://adisinsight.springer.com/trials/700304217?error=cookies_not_supported&code=1c9c1e02-b391-45cc-9da0-353eab3b1ab1 A retrospective efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma -... This study investigated efficacy and safety of pomalidomide in relapsed/refractory multiple myeloma. efficacy and safety https://pubmed.ncbi.nlm.nih.gov/33662288/ Treatment of relapsed and refractory multiple myeloma: recommendations from the International... This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple... multiple myeloma from the treatment relapsed refractory https://ub01.uni-tuebingen.de/xmlui/handle/10900/53270 Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma current and future management strategies relapsed progressive hepatoblastoma https://pure.psu.edu/en/publications/a-role-for-surgery-in-the-treatment-of-relapsed-hodgkin-lymphoma/ A role for surgery in the treatment of relapsed Hodgkin lymphoma - Penn State https://adisinsight.springer.com/trials/700392555?error=cookies_not_supported&code=07281d90-69a0-4cbb-961a-55c6d361a3b9 Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse... This clinical research study is to learn if CD70.CAR NK cell therapy can help to control early relapsed or primary refractory DLBCL and cHL. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1629465/full Frontiers | EUROCOVER-CLL: Reimbursement and accessibility of new treatments in relapsed/refractory... BackgroundDespite recent therapeutic advances in chronic lymphocytic leukemia (CLL), access to innovative treatments may still be uneven outside Western Euro... https://www.news-medical.net/health/RelapsedRefractory-Follicular-Lymphoma.aspx Relapsed/Refractory Follicular Lymphoma Dec 30, 2022 - Follicular lymphoma is a type of non-Hodgkin lymphoma that involves abnormal growth of the B-lymphocytes (B-cells). The lymphocytes with abnormal cell growth... relapsed refractory follicular lymphoma https://www.mdpi.com/2072-6694/15/3/589 Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma Historic outcomes for patients with relapsed or refractory nodal-based T-cell lymphomas are poor, with survival generally measured in months in multiple... t cell therapeutic advances relapsed refractory https://adisinsight.springer.com/trials/700373264?error=cookies_not_supported&code=cdf4bfbf-77d8-4711-98c2-8adeea0a3959 Azacytidine Combined With Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic... This is a multicenter prospective single arm phase II study. The purpose of this study is to evaluate the safety and efficiency of azacytidine combined with in the https://www.cirm.ca.gov/cirm-trial/crispr-edited-allogeneic-anti-cd19-car-t-cell-therapy-for-relapsed-refractory-b-cell-non-hodgkin-lymphoma-antler-3/ CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin... https://mochachocolatarita.blogspot.com/2009/03/soft-and-moist-banana-cake-banana.html?showComment=1238532240000 Mochachocolata-Rita: Soft and Moist Banana Cake - Banana Baking Addiction Relapsed! Baking. I was a phobic turned a junkie. A discriminative junkie, though. I have this thing about banana baked goods, I am an addict and I th... banana cake rita soft moist baking https://adisinsight.springer.com/trials/700300717?error=cookies_not_supported&code=6d47d5df-5f7b-428f-bcd6-40a95257471c Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With Relapsed/Refractory... This study will evaluate the combined efficacy of venetoclax and ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia. followed by ibrutinib lead https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-rezlidhia-olutasidenib-relapsed-or-refractory-acute-myeloid FDA D.I.S.C.O. Burst Edition: FDA approval of Rezlidhia (olutasidenib) for relapsed or refractory... Listen to a soundcast of the December 1, 2022, FDA approval of Rezlidhia (olutasidenib) for relapsed or refractory acute myeloid leukemia with a susceptible... https://scholars.uky.edu/es/publications/acute-hepatotoxicity-after-high-dose-cytarabine-for-the-treatment/ Acute Hepatotoxicity After High-Dose Cytarabine for the Treatment of Relapsed Acute Myeloid... high dose https://scholarworks.indianapolis.iu.edu/items/bdd7bdb5-829c-40af-94a4-ee9da934919d Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma: Phase 1... Background: Recognising that the immune suppressive microenvironment promotes tumour growth in Hodgkin lymphoma, we hypothesised that activating immunity might... https://pubmed.ncbi.nlm.nih.gov/34755433/ Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A... Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients https://adisinsight.springer.com/trials/700391264?error=cookies_not_supported&code=fcb56962-1fc9-4ee8-a1e8-0dc750ade851 Orelabrutinib in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia: A Prospective,... 1. wAIHA Treatment Regimen: Group A (50mg group): Orelabrutinib 50 mg, orally, once daily. After 4 weeks of treatment, if still transfusion-dependent or autoimmune hemolytic anemia in the https://mochachocolatarita.blogspot.com/2009/03/soft-and-moist-banana-cake-banana.html?showComment=1238645640000 Mochachocolata-Rita: Soft and Moist Banana Cake - Banana Baking Addiction Relapsed! Baking. I was a phobic turned a junkie. A discriminative junkie, though. I have this thing about banana baked goods, I am an addict and I th... banana cake rita soft moist baking https://www.researchandmarkets.com/reports/4989036/relapsedrefractory-epstein-barr-virus Relapsed/Refractory Epstein Barr Virus - Pipeline Insight, 2025 'Relapsed/Refractory Epstein Barr Virus Pipeline Insight, 2025' report outlays comprehensive insights of present clinical development scenario and growth... epstein barr virus relapsed refractory pipeline insight https://pubmed.ncbi.nlm.nih.gov/34166502/ CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large... Hematotoxicity represents a frequent chimeric antigen receptor (CAR) T-cell-related adverse event and remains poorly understood. In this multicenter analysis,... https://research.birmingham.ac.uk/en/publications/a-phase-12-study-of-thiotepa-based-immunochemotherapy-in-relapsed/ A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma:... https://pmc.ncbi.nlm.nih.gov/articles/PMC9198941/ Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed... One intravenous dose of oncolytic VSV has single-agent activity in patients with relapsed refractory T-cell lymphoma. Direct oncolytic tumor cell killing and... https://open.library.emory.edu/concern/publications/562eff30-22a2-4b99-9b5a-a05e5a411870 Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous... Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the... hodgkin lymphoma nivolumab relapsed refractory classic https://www.nice.org.uk/guidance/ta642 Overview | Gilteritinib for treating relapsed or refractory acute myeloid leukaemia | Guidance |... Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults acute myeloid leukaemia overview treating relapsed https://pubmed.ncbi.nlm.nih.gov/30253729/ Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? Effective therapies for relapsed/refractory meningioma after surgery and radiation therapy represent an unmet need. Most meningiomas are highly vascularized... systemic therapy relapsed refractory https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03213665&r=1 Tazemetostat in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin... Tazemetostat in Treating Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders with EZH2, SMARCB1, or... https://ub01.uni-tuebingen.de/xmlui/handle/10900/126608 Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical... stage iv relapsed neuroblastoma patients https://open.library.emory.edu/concern/publications/1769417c-bcd8-4565-8c44-ebcb897c9b4f Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One... Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in... https://aggietranscript.faculty.ucdavis.edu/safety-and-efficacy-of-car-t-cell-therapy-for-refractory-or-relapsed-b-cell-acute-lymphoblastic-leukemia/ Safety and Efficacy of CAR-T cell therapy for Refractory or Relapsed B-cell Acute Lymphoblastic... car t cell therapy https://adisinsight.springer.com/trials/700316764?error=cookies_not_supported&code=6498b6a7-4500-4fc5-8779-24e4f977bfaa Phase II Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of Relapsed,... RAPA-201-RRMM is an open-label, single-arm, non-randomized multicenter phase II study of RAPA-201 autologous T cells in adults with relapsed, refractory https://pubmed.ncbi.nlm.nih.gov/34726773/ Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma Cusatuzumab was well tolerated, and antitumor activity was observed at both 1 and 5 mg/kg in highly pretreated patients with R/R CTCL. The observed... https://adisinsight.springer.com/trials/700304784?error=cookies_not_supported&code=497cd55f-1eb2-481a-a19f-fea96847967e A phase I study of Anti-CD22 chimeric antigen receptor T cell therapy in patient relapsed and... This investigator sponsored trial will be evaluating the Anti-CD22 chimeric antigen receptor T cell therapy in patients with refractory and relapsed acute https://adisinsight.springer.com/trials/700311737?error=cookies_not_supported&code=743f56ea-eb12-4154-8654-9dc58d31d5d4 Phase I Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid... The study objective is to evaluate patient safety for patients with refractory and relapsed AML being treated with Ceramide NanoLiposome (CNL) . https://ja.dh.duke.edu/hematologic_malignancy_grand_rounds_fy18/hematologic-malignancy-grand-rounds-fy18-45 Hematologic Malignancy Grand Rounds - FY18 An Unusual Case of Relapsed ALL Old and New Treatment... https://adisinsight.springer.com/trials/700381071?error=cookies_not_supported&code=dcf1cb8b-250d-4c66-a13b-58b93a2a029b Feasibility of Treating Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma With Zanubrutinib in... This phase I trial tests zanubrutinib in combination with sonrotoclax for treating underrepresented ethnic and racial minorities with B-cell non-Hodgkin non hodgkin lymphoma https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/38516 Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia evolution relapsed mutated acute myeloid